Restricted accessResearch articleFirst published online 2016-05
Loss-of-Function of HtrA1 Abrogates All- Trans Retinoic Acid-Induced Osteogenic Differentiation of Mouse Adipose-Derived Stromal Cells Through Deficiencies in p70S6K Activation
All-trans retinoic acid (ATRA) is a potent inducer of osteogenic differentiation in mouse adipose-derived stromal cells (mASCs), although the underlying mechanisms responsible for its mode of action have yet to be completely elucidated. High temperature requirement protease A1 (HtrA1) is a newly recognized modulator of human multipotent stromal cell (MSC) osteogenesis and as such, may play a role in regulating ATRA-dependent osteogenic differentiation of mASCs. In this study, we assessed the influence of small interfering RNA (siRNA)-induced repression of HtrA1 production on mASC osteogenesis and examined its effects on ATRA-mediated mammalian target of rapamycin (mTOR) signaling. Inhibition of HtrA1 production in osteogenic mASCs resulted in a significant reduction of alkaline phosphatase activity and mineralized matrix formation. Western blot analyses revealed the rapid activation of Akt (Ser473) and p70S6K (Thr389) in ATRA-treated mASCs, and that levels of phosphorylated p70S6K were noticeably reduced in HtrA1-deficient mASCs. Further studies using mTOR inhibitor rapamycin and siRNA specific for the p70S6K gene Rps6kb1 confirmed ATRA-mediated mASC osteogenesis as being dependent on p70S6K activation. Finally, transfection of cells with a constitutively active rapamycin-resistant p70S6K mutant could restore the mineralizing capacity of HtrA1-deficient mASCs. These findings therefore lend further support for HtrA1 as a positive mediator of MSC osteogenesis and provide new insights into the molecular mode of action of ATRA in regulating mASC lineage commitment.
Get full access to this article
View all access options for this article.
References
1.
WanDC, ShiYY, NacamuliRP, QuartoN, LyonsKM and LongakerMT. (2006). Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proc Natl Acad Sci U S A, 103:12335–12340.
2.
WanDC, SiedhoffMT, KwanMD, NacamuliRP, WuBM and LongakerMT. (2007). Refining retinoic acid stimulation for osteogenic differentiation of murine adipose-derived adult stromal cells. Tissue Eng, 13:1623–1631.
3.
MalladiP, XuY, YangGP and LongakerMT. (2006). Functions of vitamin D, retinoic acid, and dexamethasone in mouse adipose-derived mesenchymal cells. Tissue Eng, 12:2031–2040.
4.
MirsaidiA, KleinhansKN, RimannM, TiadenAN, StauberM, RudolphKL and RichardsPJ. (2012). Telomere length, telomerase activity and osteogenic differentiation are maintained in adipose-derived stromal cells from senile osteoporotic SAMP6 mice. J Tissue Eng Regen Med, 6:378–390.
5.
MirsaidiA, GenelinK, VetschJR, StangerS, TheissF, LindtnerRA, von RechenbergB, BlauthM, MüllerR, et al. (2014). Therapeutic potential of adipose-derived stromal cells in age-related osteoporosis. Biomaterials, 35:7326–7335.
6.
MirsaidiA, TiadenAN and RichardsPJ. (2013). Preparation and osteogenic differentiation of scaffold-free mouse adipose-derived stromal cell microtissue spheroids (ASC-MT). Curr Protoc Stem Cell Biol, 27: Unit 2B.5.
7.
TiadenAN, BreidenM, MirsaidiA, WeberFA, BahrenbergG, GlanzS, CinelliP, EhrmannM and RichardsPJ. (2012). Human serine protease HTRA1 positively regulates osteogenesis of human bone marrow-derived mesenchymal stem cells and mineralization of differentiating bone-forming cells through the modulation of extracellular matrix protein. Stem Cells, 30:2271–2282.
8.
HamidoucheZ, HaÿE, VaudinP, CharbordP, SchüleR, MariePJ and FromiguéO. (2008). FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. FASEB J, 22:3813–3822.
9.
HisadaK, HataK, IchidaF, MatsubaraT, OrimoH, NakanoT, YataniH, NishimuraR and YonedaT. (2013). Retinoic acid regulates commitment of undifferentiated mesenchymal stem cells into osteoblasts and adipocytes. J Bone Miner Metab, 31:53–63.
OhishiK, NishikawaS, NagataT, YamauchiN, ShinoharaH, KidoJ and IshidaH. (1995). Physiological concentrations of retinoic acid suppress the osteoblastic differentiation of fetal rat calvaria cells in vitro. Eur J Endocrinol, 133:335–341.
12.
IbaK, ChibaH, YamashitaT, IshiiS and SawadaN. (2001). Phase-independent inhibition by retinoic acid of mineralization correlated with loss of tetranectin expression in a human osteoblastic cell line. Cell Struct Funct, 26:227–233.
13.
LindT, SundqvistA, HuL, PejlerG, AnderssonG, JacobsonA and MelhusH. (2013). Vitamin a is a negative regulator of osteoblast mineralization. PLoS One, 8:e82388.
14.
CowanCM, AalamiOO, ShiYY, ChouYF, MariC, ThomasR, QuartoN, NacamuliRP, ContagCH, WuB and LongakerMT. (2005). Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng, 11:645–658.
15.
ClausenT, KaiserM, HuberR and EhrmannM. (2011). HTRA proteases: regulated proteolysis in protein quality control. Nat Rev Mol Cell Biol, 12:152–162.
16.
CampioniM, SeverinoA, ManenteL, TuduceIL, ToldoS, CaragliaM, CrispiS, EhrmannM, HeX, et al. (2010). The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein. Mol Cancer Res, 8:1248–1260.
17.
SinghaUK, JiangY, YuS, LuoM, LuY, ZhangJ and XiaoG. (2008). Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells. J Cell Biochem, 103:434–446.
18.
IsomotoS, HattoriK, OhgushiH, NakajimaH, TanakaY and TakakuraY. (2007). Rapamycin as an inhibitor of osteogenic differentiation in bone marrow-derived mesenchymal stem cells. J Orthop Sci, 12:83–88.
19.
ShobaLN and LeeJC. (2003). Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks osteogenic protein-1 induction of alkaline phosphatase activity in fetal rat calvaria cells. J Cell Biochem, 88:1247–1255.
20.
GrauS, RichardsPJ, KerrB, HughesC, CatersonB, WilliamsAS, JunkerU, JonesSA, ClausenT and EhrmannM. (2006). The role of human HtrA1 in arthritic disease. J Biol Chem, 281:6124–6129.
21.
SchalmSS and BlenisJ. (2002). Identification of a conserved motif required for mTOR signaling. Curr Biol, 12:632–639.
22.
SchipperBM, MarraKG, ZhangW, DonnenbergAD and RubinJP. (2008). Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg, 60:538–544.
23.
ZhuM, KohanE, BradleyJ, HedrickM, BenhaimP and ZukP. (2009). The effect of age on osteogenic, adipogenic and proliferative potential of female adipose-derived stem cells. J Tissue Eng Regen Med, 3:290–301.
24.
KhanWS, AdesidaAB, TewSR, AndrewJG and HardinghamTE. (2009). The epitope characterization and the osteogenic differentiation potential of human fat pad-derived stem cells is maintained with ageing in later life. Injury, 40:150–157.
25.
ShiYY, NacamuliRP, SalimA and LongakerMT. (2005). The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plast Reconstr Surg, 116:1686–1696.
26.
LiuHY, ChiouJF, WuAT, TsaiCY, LeuJD, TingLL, WangMF, ChenHY, LinCT, WilliamsDF and DengWP. (2012). The effect of diminished osteogenic signals on reduced osteoporosis recovery in aged mice and the potential therapeutic use of adipose-derived stem cells. Biomaterials, 33:6105–6112.
27.
YouL, PanL, ChenL, ChenJY, ZhangX, LvZ and FuD. (2012). Suppression of zinc finger protein 467 alleviates osteoporosis through promoting differentiation of adipose derived stem cells to osteoblasts. J Transl Med, 10:11.
28.
ZumbrunnJ and TruebB. (1996). Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett, 398:187–192.
29.
TiadenAN and RichardsPJ. (2013). The emerging roles of HTRA1 in musculoskeletal disease. Am J Pathol, 182:1482–1488.
30.
GrahamJR, ChamberlandA, LinQ, LiXJ, DaiD, ZengW, RyanMS, Rivera-BermúdezMA, FlanneryCR and YangZ. (2013). Serine protease HTRA1 antagonizes transforming growth factor-β signaling by cleaving its receptors and loss of HTRA1 in vivo enhances bone formation. PLoS One, 8:e74094.
31.
WuX, ChimSM, KuekV, LimBS, ChowST, ZhaoJ, YangS, RosenV, TicknerJ and XuJ. (2014). HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylation. FEBS Lett, 588:143–150.
32.
TiadenAN, KlawitterM, LuxV, MirsaidiA, BahrenbergG, GlanzS, QueroL, LiebscherT, WuertzK, EhrmannM and RichardsPJ. (2012). Detrimental role for human high temperature requirement serine protease A1 (HTRA1) in the pathogenesis of intervertebral disc (IVD) degeneration. J Biol Chem, 287:21335–21345.
33.
ChienJ, OtaT, AlettiG, ShridharR, BoccellinoM, QuagliuoloL, BaldiA and ShridharV. (2009). Serine protease HtrA1 associates with microtubules and inhibits cell migration. Mol Cell Biol, 29:4177–4187.
34.
ShigaA, NozakiH, YokosekiA, NihonmatsuM, KawataH, KatoT, KoyamaA, ArimaK, IkedaM, et al. (2011). Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-β1 via cleavage of proTGF-β1. Hum Mol Genet, 20:1800–1810.
35.
TennstaedtA, PöpselS, TruebesteinL, HauskeP, BrockmannA, SchmidtN, IrleI, SaccaB, NiemeyerCM, et al. (2012). Human high temperature requirement serine protease A1 (HTRA1) degrades tau protein aggregates. J Biol Chem, 287:20931–20941.
36.
HeX, KhuranaA, MaguireJL, ChienJ and ShridharV. (2012). HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation. Int J Cancer, 130:1029–1035.
37.
ZoncuR, EfeyanA and SabatiniDM. (2011). mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol, 12:21–35.
38.
KimJ, JungY, SunH, JosephJ, MishraA, ShiozawaY, WangJ, KrebsbachPH and TaichmanRS. (2012). Erythropoietin mediated bone formation is regulated by mTOR signaling. J Cell Biochem, 113:220–228.
39.
KimJK, BakerJ, NorJE and HillEE. (2011). mTor Plays an Important Role in Odontoblast Differentiation. J Endod, 37:1081–1085.
40.
TangC-H, LuDY, TanTW, FuWM and YangRS. (2007). Ultrasound Induces Hypoxia-inducible Factor-1 Activation and Inducible Nitricoxide synthase expression through the Integrin/Integrin-linked Kinase/Akt/Mammalian target of rapamycin pathway in osteoblasts. J Biol Chem, 282:25406–25415.
41.
TeeAR, ManningBD, RouxPP, CantleyLC and BlenisJ. (2003). Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol, 13:1259–1268.
42.
LaL, LiY, SmithJ, SassanoA, UddinS, ParmarS, TallmanMS, MinucciS, HayN and PlataniasLC. (2005). Activation of the p70 S6 kinase by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood, 105:1669–1677.
43.
BusadaJT, ChappellVA, NiedenbergerBA, KayeEP, KeiperBD, HogarthCA and GeyerCB. (2015). Retinoic acid regulates Kit translation during spermatogonial differentiation in the mouse. Dev Biol, 397:140–149.
44.
ChenN and NapoliJL. (2008). All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RARalpha. FASEB J, 22:236–245.
45.
MasiáS, AlvarezS, de LeraAR and BarettinoD. (2007). Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. Mol Endocrinol, 21:2391–2402.
46.
GiannìM, BauerA, GarattiniE, ChambonP and Rochette-EglyC. (2002). Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation. EMBO J, 21:3760–3769.
47.
AlsayedY, UddinS, MahmudN, LekmineF, KalvakolanuDV, MinucciS, BokochG and PlataniasLC. (2001). Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem, 276:4012–4019.
48.
BostF, CaronL, MarchettiI, DaniC, Le Marchand-BrustelY and BinétruyB. (2002). Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem J, 361:621–627.
49.
Tanoury ZAI, PiskunovA and Rochette-EglyC. (2013). Vitamin A and retinoid signaling: genomic and nongenomic effects. J Lipid Res, 54:1761–1775.
50.
ChiangGG and AbrahamRT. (2005). Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem, 280:25485–25490.
CarnevalliLS, MasudaK, FrigerioF, Le BacquerO, UmSH, GandinV, TopisirovicI, SonenbergN, ThomasG and KozmaSC. (2010). S6K1 plays a critical role in early adipocyte differentiation. Dev Cell, 18:763–774.
53.
InokiK, LiY, XuT and GuanKL. (2003). Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev, 17:1829–1834.
54.
JaeschkeA, HartkampJ, SaitohM, RoworthW, NobukuniT, HodgesA, SampsonJ, ThomasG and LambR. (2002). Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J Cell Biol, 159:217–224.
55.
Vander HaarE, LeeSI, BandhakaviS, GriffinTJ and KimDH. (2007). Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol, 9:316–323.
56.
DanHC, EbbsA, PasparakisM, Van DykeT, BasseresDS and BaldwinAS. (2014). Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα). J Biol Chem, 289:25227–25240.
57.
HadfieldKD, RockCF, InksonCA, DallasSL, SudreL, WallisGA, Boot-HandfordRP and CanfieldAE. (2008). HtrA1 inhibits mineral deposition by osteoblasts: requirement for the protease and PDZ domains. J Biol Chem, 283:5928–5938.
58.
LiR and ZhangQ. (2015). HtrA1 may regulate the osteogenic differentiation of human periodontal ligament cells by TGF-β1. J Mol Histol, 46:137–144.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
